United Kingdom Soft Gelatin Capsules Market Research Report: Size, Share, Trends & Forecast (2026-2032)

By Type (Gelatin Soft Capsules, Non-Gelatin (Vegetarian) Soft Capsules), By Application (Pharmaceutical, Nutraceutical, Cosmeceutical), By End User (Pharmaceutical Companies, Nutraceutical Companies,... ... ceutical Companies, Contract Manufacturing Organizations (CMOs/CDMOs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Read more

  • Chemicals
  • Mar 2026
  • 170
  • PDF, Excel, PPT

United Kingdom Soft Gelatin Capsules Market Report Key Takeaways:

  • The United Kingdom Soft Gelatin Capsules Market size was valued at around USD 275 million in 2025 and is projected to grow from USD 290.95 million in 2026 to USD 408.07 million by 2032, exhibiting a CAGR of 5.8% during 2026-32.
  • By Type, the Gelatin Soft Capsules segment represented a significant share of about 78% in the United Kingdom Soft Gelatin Capsules Market in 2026.
  • By Application, the Nutraceutical segment seized a significant share of about 51% in the United Kingdom Soft Gelatin Capsules Market in 2026.
  • Leading soft gelatin capsule companies in the U.K. market are EuroCaps Ltd., Catalent Inc., Aenova Group, Lonza Group Ltd., Soft Gel Technologies Inc., Captek Softgel International, INW Bee Health Ltd., Supplement Factory Ltd., HTC Health Ltd., Nutra Direct Ltd., NextPharma, Strides Pharma Science Ltd., Cloverty Ltd., and others.

Market Insights & Analysis: United Kingdom Soft Gelatin Capsules Market (2026-32):

The United Kingdom Soft Gelatin Capsules Market size was valued at around USD 275 million in 2025 and is projected grow from USD 290.95 million in 2026 to USD 408.07 million by 2032, exhibiting a CAGR of 5.8% during the forecast period, i.e., 2026-32.

The United Kingdom soft gelatin capsules market has experienced stable historical growth, supported by sustained expansion in healthcare spending and pharmaceutical consumption. UK NHS expenditure reached approximately USD 300 billion in 2024/25, with long-term annual growth of around 3.6%, reflecting consistent demand for medicines and drug delivery systems . This expanding expenditure base has reinforced the adoption of efficient dosage forms such as soft gelatin capsules. Over time, increasing use in both prescription therapies and over-the-counter supplements has strengthened market penetration.

Current market conditions are shaped by diversified end-user demand across pharmaceutical companies, nutraceutical manufacturers, and healthcare institutions. Retail and online pharmacies continue to expand accessibility, while hospitals maintain stable demand for capsule-based medications in chronic disease management. The UK’s Medicines and Healthcare Products Regulatory Agency enforces stringent safety, quality, and efficacy standards, ensuring high product reliability and strengthening trust in capsule-based formulations . This robust regulatory framework supports consistent product adoption across institutional and commercial channels.

Government-led initiatives and industry investments further reinforce market expansion by promoting innovation and domestic pharmaceutical capabilities. The UK government’s focus on supply chain resilience has encouraged investment in local manufacturing infrastructure and medicine production reliability. In parallel, companies such as GSK have committed approximately USD 30 billion toward R&D and manufacturing capacity, while AstraZeneca continues to leverage its UK-based innovation hub alongside global expansion . These developments collectively strengthen production capabilities and support advanced drug delivery technologies.

Looking ahead, the market is expected to maintain stable growth driven by demographic aging, rising prevalence of chronic diseases, and increasing consumer focus on preventive healthcare. Industry participants are investing in plant-based softgel technologies, improved bioavailability formulations, and sustainable manufacturing practices. Continued expansion of nutraceutical consumption and institutional healthcare demand will further support market stability. These combined economic, regulatory, and industry-driven factors are expected to sustain long-term demand for soft gelatin capsules in the United Kingdom.

United Kingdom Soft Gelatin Capsules Market Recent Developments:

  • 2024: Roquette launched its LYCAGEL® Flex softgel excipient system, enabling manufacturers to develop customizable plant-based softgel capsules with enhanced stability, performance, and formulation flexibility. The innovation supports the growing shift toward vegan softgels in nutraceutical and pharmaceutical applications.

United Kingdom Soft Gelatin Capsules Market Scope:

 Category  Segments
By Type (Gelatin Soft Capsules, Non-Gelatin (Vegetarian) Soft Capsules),
By Application (Pharmaceutical, Nutraceutical, Cosmeceutical),
By End User (Pharmaceutical Companies, Nutraceutical Companies, Contract Manufacturing Organizations (CMOs/CDMOs)),
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

United Kingdom Soft Gelatin Capsules Market Driver:

Aging Population and Chronic Disease Burden

The aging population in the United Kingdom has emerged as a fundamental structural driver of healthcare demand, intensifying steadily in recent years. According to the Office for National Statistics, individuals aged 65 and above accounted for approximately 19.5% of the population in 2024, reflecting a rapidly expanding elderly demographic . This shift is directly associated with a higher prevalence of chronic conditions such as cardiovascular diseases, diabetes, and arthritis. As life expectancy increases, long-term medication and supplement consumption have become more widespread, structurally expanding demand for oral dosage forms.

This demographic trend is measurably increasing demand across pharmaceutical and nutraceutical end-user segments. NHS data indicate that older adults account for a significant proportion of prescriptions due to multi-morbidity and continuous treatment requirements. Soft gelatin capsules are particularly suited to this population due to ease of swallowing and enhanced bioavailability. Supporting this context, a 2025 clinical study found that vitamin D supplementation among adults aged 50 and above could slow biological aging by nearly three years, reinforcing sustained supplement consumption among elderly populations .

The impact of this driver extends beyond short-term adoption and contributes directly to long-term market volume expansion. Government health strategies increasingly emphasize preventive care and chronic disease management, as reflected in the UK’s 2025 NHS 10-Year Health Plan , which prioritizes a systemic shift toward early intervention and long-term health management. This policy direction ensures continuous demand for medicines and supplements. As a result, the expanding elderly population increases both the number of consumers and the duration of treatment, structurally driving sustained demand for soft gelatin capsules.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. United Kingdom Soft Gelatin Capsules Market Policies, Regulations, and Product Standards
  5. United Kingdom Soft Gelatin Capsules Market Trends & Developments
  6. United Kingdom Soft Gelatin Capsules Market Dynamics
    1. Growth Factors
    2. Challenges
  7. United Kingdom Soft Gelatin Capsules Market Hotspot & Opportunities
  8. United Kingdom Soft Gelatin Capsules Market Outlook, 2022-2032F
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Tons)
    2. Market Share & Outlook
      1. By Type- Market Size & Forecast 2022-2032, USD Million & Million Tons
        1. Gelatin Soft Capsules
        2. Non-Gelatin (Vegetarian) Soft Capsules
      2. By Application- Market Size & Forecast 2022-2032, USD Million & Million Tons
        1. Pharmaceutical
        2. Nutraceutical
        3. Cosmeceutical
      3. By End User- Market Size & Forecast 2022-2032, USD Million & Million Tons
        1. Pharmaceutical Companies
        2. Nutraceutical Companies
        3. Contract Manufacturing Organizations (CMOs/CDMOs)
      4. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million & Million Tons
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  9. United Kingdom Gelatin Soft Capsules Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Tons)
    2. Market Share & Outlook
      1. By Application- Market Size & Forecast 2022-2032, USD Million & Million Tons
      2. By End User- Market Size & Forecast 2022-2032, USD Million & Million Tons
      3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million & Million Tons
  10. United Kingdom Non-Gelatin (Vegetarian) Soft Capsules Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Tons)
    2. Market Share & Outlook
      1. By Application- Market Size & Forecast 2022-2032, USD Million & Million Tons
      2. By End User- Market Size & Forecast 2022-2032, USD Million & Million Tons
      3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million & Million Tons
  11. United Kingdom Soft Gelatin Capsules Market Key Strategic Imperatives for Success & Growth
  12. Competitive Outlook
    1. Company Profiles
      1. EuroCaps Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Catalent Inc.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Aenova Group
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Lonza Group Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Soft Gel Technologies Inc.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Captek Softgel International
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. INW Bee Health Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Supplement Factory Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. HTC Health Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Nutra Direct Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      11. NextPharma Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Strides Pharma Science Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Cloverty Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
  13. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .